Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Repository of the University of Ljubljana
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Advanced
New in RUL
About RUL
In numbers
Help
Sign in
Details
Dynamics of leukocyte telomere length in patients with Fabry disease
ID
Levstek, Tina
(
Author
),
ID
Breznik, Nika
(
Author
),
ID
Vujkovac, Bojan
(
Author
),
ID
Nowak, Albina
(
Author
),
ID
Trebušak Podkrajšek, Katarina
(
Author
)
PDF - Presentation file,
Download
(731,45 KB)
MD5: A759E4D57021AA05463423E5FC00CA8F
URL - Source URL, Visit
https://www.mdpi.com/2227-9059/12/8/1724
Image galllery
Abstract
Fabry disease (FD) leads to significant morbidity and mortality, which may indicate accelerated ageing. However, it is still unclear whether there is a relationship between telomere length (TL), a marker of biological ageing, and disease outcome. We aimed to examine the relationship between leukocyte TL (LTL) dynamics and the presence of advanced disease stages and/or late complications of FD, including hypertrophic cardiomyopathy, nephropathy and stroke, both cross-sectionally and longitudinally. DNA was extracted from peripheral blood leukocytes and quantitative PCR was utilized to determine relative LTL in 99 Fabry patients. In the longitudinal analysis, we included 50 patients in whom at least three measurements were performed over a period of 5–10 years. The results showed a significant inverse correlation between LTL and age (ρ = −0.20, p = 0.05). No significant differences in LTL were found between females and males (p = 0.79) or between patients receiving disease-specific therapy and those without (p = 0.34). In a cross-sectional analysis, no association was found between the presence (p = 0.15) or number (p = 0.28) of advanced stages of the disease and/or late complications and LTL. Similarly, in a longitudinal analysis, no difference in LTL dynamics was found regarding the presence (p = 0.16) of advanced stage organ involvement and/or late complications or their number. These findings indicate that LTL dynamics in adulthood may not be a reliable indicator of disease outcomes in Fabry patients. Therefore, LTL may more accurately reflect the disease burden in early life, when TL is primarily determined.
Language:
English
Keywords:
Fabry disease
,
telomere length
,
hyperthropic cardiomyopathy
,
nephropathy
,
stroke
Work type:
Article
Typology:
1.01 - Original Scientific Article
Organization:
MF - Faculty of Medicine
Publication status:
Published
Publication version:
Version of Record
Year:
2024
Number of pages:
9 str.
Numbering:
Vol. 12, iss. 8, art. 1724
PID:
20.500.12556/RUL-166796
UDC:
616-07
ISSN on article:
2227-9059
DOI:
10.3390/biomedicines12081724
COBISS.SI-ID:
203575043
Publication date in RUL:
24.01.2025
Views:
864
Downloads:
264
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
Biomedicines
Shortened title:
Biomedicines
Publisher:
MDPI
ISSN:
2227-9059
COBISS.SI-ID:
523006745
Licences
License:
CC BY 4.0, Creative Commons Attribution 4.0 International
Link:
http://creativecommons.org/licenses/by/4.0/
Description:
This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Secondary language
Language:
Slovenian
Keywords:
Fabrijeva bolezen
,
dolžina telomer
,
hipertrofična kardiomiopatija
,
nefropatija
,
kap
Projects
Funder:
ARRS - Slovenian Research Agency
Project number:
P1-0170
Name:
Molekulski mehanizmi uravnavanja celičnih procesov v povezavi z nekaterimi boleznimi pri človeku
Funder:
ARRS - Slovenian Research Agency
Project number:
J3-50113
Name:
Prepoznavanje in longitudinalna opredelitev bioloških označevalcev razvoja in napredovanja nefropatije pri Fabryjevi bolezni
Funder:
Other - Other funder or multiple funders
Funding programme:
Takeda Pharmaceuticals
Funder:
Other - Other funder or multiple funders
Funding programme:
University Foundation of ing. Lenarčič Milan
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back